{
    "title": "Drugmaker Viatris to divest some businesses for $3.6 bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12582257/Drugmaker-Viatris-divest-businesses.html",
    "date": "2023-10-01",
    "keywords": [
        "business",
        "viatris",
        "company",
        "drug",
        "part",
        "dysfunction",
        "viagra",
        "portfolio",
        "treatment",
        "sunday",
        "total",
        "move",
        "strategy",
        "focus",
        "core",
        "gastroenterology",
        "dermatology",
        "offer",
        "consumer",
        "health",
        "nasal",
        "spray",
        "dymista",
        "otc",
        "drugmaker",
        "healthcare",
        "insud",
        "pharma",
        "india",
        "merger",
        "mylan",
        "pfizer",
        "arthritis",
        "celebrex",
        "epilepsy",
        "lyrica",
        "zoloft",
        "duphaston",
        "femoston",
        "theramex",
        "commercialization",
        "noncore",
        "combination",
        "biosimilar",
        "year",
        "deal",
        "beat",
        "wall",
        "street",
        "secondquarter",
        "revenue",
        "strength",
        "reporting",
        "akanksha",
        "khushi",
        "shubham",
        "bengaluru",
        "editing",
        "shumaker",
        "aurora",
        "ellis",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}